These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

206 related items for PubMed ID: 7362769

  • 1. Is tumour radiosensitization by misonidazole a general phenomenon?
    Denekamp J, Hirst DG, Stewart FA, Terry NH.
    Br J Cancer; 1980 Jan; 41(1):1-9. PubMed ID: 7362769
    [Abstract] [Full Text] [Related]

  • 2. Interaction of misonidazole and WR-2721--II. Modification of tumour radiosensitization.
    Rojas A, Stewart FA, Denekamp J.
    Br J Cancer; 1983 Jan; 47(1):65-72. PubMed ID: 6295429
    [Abstract] [Full Text] [Related]

  • 3. Comparative study of thermoradiosensitization by misonidazole and metronidazole in vivo: antitumour effect and pharmacokinetics.
    Wong KH, Maezawa H, Urano M.
    Int J Hyperthermia; 1992 Jan; 8(5):645-58. PubMed ID: 1402141
    [Abstract] [Full Text] [Related]

  • 4. Effect of misonidazole and hyperthermia on the radiosensitivity of a C3H mouse mammary carcinoma and its surrounding normal tissue.
    Overgaard J.
    Br J Cancer; 1980 Jan; 41(1):10-21. PubMed ID: 7362770
    [Abstract] [Full Text] [Related]

  • 5. Response of murine tumours to combinations of CCNU with misonidazole and other radiation sensitizers.
    Siemann DW.
    Br J Cancer; 1982 Feb; 45(2):272-81. PubMed ID: 6460517
    [Abstract] [Full Text] [Related]

  • 6. In vivo interaction of anti-cancer drugs with misonidazole or metronidazole: methotrexate, 5-fluorouracil and adriamycin.
    Tannock IF.
    Br J Cancer; 1980 Dec; 42(6):861-70. PubMed ID: 7459220
    [Abstract] [Full Text] [Related]

  • 7. Enhancing effect of misonidazole on the response of the RIF-1 tumour to cyclophosphamide.
    Law MP, Hirst DG, Brown JM.
    Br J Cancer; 1981 Aug; 44(2):208-18. PubMed ID: 7272187
    [Abstract] [Full Text] [Related]

  • 8. Tumor sensitizing effect by misonidazole in a clinically relevant radiation dose range.
    Grdina DJ, Thames HD, Milas L.
    Int J Radiat Oncol Biol Phys; 1984 Mar; 10(3):379-83. PubMed ID: 6706731
    [Abstract] [Full Text] [Related]

  • 9. Radiosensitization of tumors and normal tissues by combined treatment with misonidazole and heat.
    Hofer KG, MacKinnon AR, Schubert AL, Lehr JE, Grimmett EV.
    Radiology; 1981 Dec; 141(3):801-9. PubMed ID: 7302238
    [Abstract] [Full Text] [Related]

  • 10. Studies of the in vivo and in vitro cytotoxicity of the drug RSU-1069.
    Hill RP, Gulyas S, Whitmore GF.
    Br J Cancer; 1986 Jun; 53(6):743-51. PubMed ID: 3755053
    [Abstract] [Full Text] [Related]

  • 11. Effect of hyperthermia and misonidazole on the radiosensitivity of a transplantable murine tumor: influence of factors modifying the fraction of hypoxic cells.
    Wondergem J, Haveman J, van der Schueren E, van den Hoeven H, Breur K.
    Int J Radiat Oncol Biol Phys; 1982 Aug; 8(8):1323-31. PubMed ID: 7141911
    [Abstract] [Full Text] [Related]

  • 12. Enhancement of melphalan-induced tumour cell killing by misonidazole: an interaction of competing mechanisms.
    Horsman MR, Evans JW, Brown JM.
    Br J Cancer; 1984 Sep; 50(3):305-16. PubMed ID: 6466544
    [Abstract] [Full Text] [Related]

  • 13. In vivo interaction of anti-cancer drugs with misonidazole or metronidazole: cyclophosphamide and BCNU.
    Tannock IF.
    Br J Cancer; 1980 Dec; 42(6):871-80. PubMed ID: 7459221
    [Abstract] [Full Text] [Related]

  • 14. In vivo combination of misonidazole and the chemotherapeutic agent CCNU.
    Siemann DW.
    Br J Cancer; 1981 Mar; 43(3):367-77. PubMed ID: 7225287
    [Abstract] [Full Text] [Related]

  • 15. Effect of clinical levels of misonidazole on the response of tumour and normal tissues in the mouse to alkylating agents.
    Brown JM, Hirst DG.
    Br J Cancer; 1982 May; 45(5):700-8. PubMed ID: 7082556
    [Abstract] [Full Text] [Related]

  • 16. The effect of prolonged high dose misonidazole on tumor response to radiation.
    McNally NJ, de Ronde J, Hinchliffe M.
    Int J Radiat Oncol Biol Phys; 1984 Aug; 10(8):1281-5. PubMed ID: 6469751
    [Abstract] [Full Text] [Related]

  • 17. A comparative investigation of nimorazole and misonidazole as hypoxic radiosensitizers in a C3H mammary carcinoma in vivo.
    Overgaard J, Overgaard M, Nielsen OS, Pedersen AK, Timothy AR.
    Br J Cancer; 1982 Dec; 46(6):904-11. PubMed ID: 7150484
    [Abstract] [Full Text] [Related]

  • 18. Skin sensitization by misonidazole: a demonstration of uniform mild hypoxia.
    Stewart FA, Denekamp J, Randhawa VS.
    Br J Cancer; 1982 Jun; 45(6):869-77. PubMed ID: 7093121
    [Abstract] [Full Text] [Related]

  • 19. Misonidazole and CCNU: further evidence for a pharmacokinetic mechanism of chemosensitization and therapeutic gain.
    Lee FY, Workman P.
    Br J Cancer; 1984 May; 49(5):579-85. PubMed ID: 6722006
    [Abstract] [Full Text] [Related]

  • 20. Radiosensitization in multifraction schedules. II. Greater sensitization by 2-nitroimidazoles than by oxygen.
    Taylor YC, Brown JM.
    Radiat Res; 1987 Oct; 112(1):134-45. PubMed ID: 3659294
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.